Clinical Trials Browser

OTHER × Kenny-Caffey syndrome, Type 1 × Clear all

NCT05574673 2026-02-27

HERO

Kenny-Caffey syndrome, Type 1, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06152731 2025-09-17

HERO

Phase 2 Recruiting

Kenny-Caffey syndrome, Type 1, Ovarian Neoplasms

NCT05732129 2023-02-24

The Efficacy and Safety of Fluzoparib Plus Irinotecan as Second-line Treatment in Patients With Homologous Recombination Deficiency (HRD) Metastatic Colorectal Cancer.

Phase 2 Unknown

Kenny-Caffey syndrome, Type 1

NCT05044091 2021-09-14

HOPEI

Kenny-Caffey syndrome, Type 1, Ovarian Neoplasms

NCT02789332 2020-03-17

GeparOla

Phase 2 Completed

Kenny-Caffey syndrome, Type 1, Breast Neoplasms, Triple Negative Breast Neoplasms